Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for raltegravir ...

Granules India receives US FDA's ANDA approval for Trazodone Hydrochloride Tablets USP, 50 mg, 100 mg, 150 mg, 300 mg Trazodone tablets are indicated for the treatment of major depressive disorder ...

The American medicine regulatory body has “approved the Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 ...

Drugmaker Granules India has received U.S. Food and Drug Administration (U.S. FDA) approval for its abbreviated new drug application for Losartan and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg ...

Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ...

The product will be manufactured at Lupin’s Pithampur facility in India. Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6 ...

This time the company is Aurobindo Pharma USA, Inc. The blood pressure medication being recalled is Quinapril and Hydrochlorothiazide Tablets USP in 20 mg and 12.5 mg doses, respectively.

Aurobindo has voluntarily recalled 2 lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg due to the presence of a nitrosamine impurity.

The recall involves Quinapril and Hydrochlorothiazide Tablets USP, 20mg / 12.5mg, supplied in 90's HDPE bottle, with lot code QE2021005-A and QE2021010-A, and expiry of 01/2023.